抗体疗法的理论基础是什么？
虽然这种抗体疗法无法分辨T细胞的正常与否，但结果证明这一招相当成功。
Although this antibody treatment cannot distinguish between normal and misbehaving t cells, the gambit has proved successful.
现在，国立老年研究所正尝试一种已被广泛用于免疫失调疾病的抗体疗法，即静脉注射免疫球蛋白。
Now, the National Institute on Aging is sponsoring a new trial of an antibody-based therapy already used to treat immune disorders: intravenous injection of immunoglobulins.
应用推荐